791 Phase 2 study of neoadjuvant sorafenib plus cisplatin...

European Urology Supplements 2014 / 04 Vol. 13; Iss. 1

791 Phase 2 study of neoadjuvant sorafenib plus cisplatin and gemcitabine (S-CG) for patients with muscle-invasive transitional cell carcinoma of the bladder (MIBC): Results at the end of first stage (NCT01222676)

Necchi, A., Mariani, L., Giannatempo, P., Fina, E., Nicolai, N., Pennati, M., Zaffaroni, N., Farè, E., Piva, L., Biasoni, D., Catanzaro, M., Torelli, T., Stagni, S., Maffezzini, M., Colecchia, M., Pao
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(14)60779-X
Date:
April, 2014
File:
PDF, 201 KB
english, 2014
Conversion to is in progress
Conversion to is failed